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Summary 
A novel heterologous expression system was used to 
examine the coupling of metabotropic glutamate re- 
ceptors (mGluRs) to neuronal voltage-gated ion chan- 
nels. Cytoplasm ic injection of mGluR2 cRNA into adult 
rat sympathetic neurons resulted in the expression of 
receptors that negatively coupled to N-type Ca 2+ chan- 
nels through a pertussis toxin-sensitive pathway. In- 
jection of mGluRla cRNA resulted in the expression 
of receptors that inhibited M-type K ÷ channels via a 
pertussis toxin-insensitive pathway. Coupling was re- 
stricted to specific transduction elements and ef- 
fectors, since mGluR2 did not inhibit M channels and 
mGluRla had minimal effects on Ca 2÷ channels. These 
findings demonstrate that heterologously expressed, 
and thus unambiguously identified, mGluR subtypes 
modulate specific neuronal ion channels through dis- 
crete signal transduction pathways. 
Introduction 
Two families of receptors, ionotropic and metabotropic, 
are known to mediate the actions of glutamate in the mam- 
malian CNS. Ionotropic glutamate receptors (iGluRs) are 
heteromultimeric proteins that contain an integral ion 
channel and account for the majority of fast excitatory 
synaptic transmission in the mammalian CNS. In contrast, 
the metabotropic glutamate receptor (mGluR) family is 
comprised of monomeric proteins that couple to effectors 
(e.g., ion channels and enzymes) by interacting with het- 
erotrimeric guanine nucleotide-binding proteins (G proteins). 
At present, seven distinct mGluR subtypes (mGluR1-7) 
have been cloned, along with splice variants of mGluR1, 
mGluR4, and mGluR5. The mGluR subtypes can be ar- 
ranged into three groups based on agonist pharmacology, 
coupling to specific signal transduction pathways, and se- 
quence homology (recently reviewed by Hollman and 
Heinemann, 1994; Nakanishi, 1994; Nakanishi and Masu, 
1994; Pin and Duvoisin, 1995). Group I receptors, com- 
prised of splice variants of mGluR1 and mGluR5, are po- 
tently activated by L-quisqualate and produce large in- 
creases in inositol phosphate (IP) turnover in stably 
transfected clonal cells (Houamed et al., 1991; Masu et 
al., 1991; Aramori and Nakanishi, 1992; Abe et al., 1992; 
Pin et al., 1992; Thomsen et al., 1993). Conversely, group 
II (mGluR2 and mGluR3) and III (mGluR4, mGluR6, and 
mGluR7) receptors, when expressed in nonneuronal sys- 
tems, have little effect on IP turnover, negatively couple 
to adenylate cyclase (AC), and are relatively insensitive to 
L-quisqualate (Tanabe et al., 1992; Nakajima et al., 1993; 
Tanabe et al., 1993; Okamoto et al., 1994; Saugstad et 
al., 1994). Group II and III receptors can be functionally 
distinguished on the basis of agonist pharmacology. 
(2S,l'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine (DCG- 
IV) and (2S, l'S,2's)-2-(carboxycyclopropyl) glycine (L-CCG-I) 
appear to be relatively specific agonists of group II mGlu Rs 
(Hayashi et al., 1992; Hayashi et al., 1993), whereas L-2- 
amino-4-phosphonobutyric a id (L-AP4) and L-serine-O- 
phosphate (L-SOP) are relatively specific agonists of 
group III mGluRs (Tanabe et al., 1993; Nakajima et al., 
1993; Okamoto et al., 1994; Saugstad et al., 1994). 
Natively expressed mGluRs are involved in a variety of 
important physiological functions in CNS neurons, includ- 
ing ion channel modulation, regulation of neurotransmitter 
release, and possibly modulation of long-term potentiation 
and depression (Pin and Duvoisin, 1995). Moreover, 
mGluRs may play a role in pathological processes such 
as epilepsy and excitotoxicity (Schoepp and Conn, 1993). 
Thus, there is a substantial interest in developing subtype- 
specific pharmacological agents and defining the role sub- 
served by specific mGluR subtypes. The recent availability 
of cDNA clones for the mGluRs has generated much new 
knowledge concerning the function of specific mGluR sub- 
types; however, the application of this information to neu- 
ronal function has generally required extrapolation of data 
derived from heterologous expression in nonneuronal 
cells. In this study, we show that injection of cRNA coding 
for specific mGluRs into the cytoplasm of neurons nor- 
mally devoid of these receptors, namely adult rat sympa- 
thetic neurons, results in the rapid and robust expression 
of mGluRs. We use this expression strategy to investigate 
the subtype-specific oupling of mGluRla and mGluR2 
to endogenous N-type Ca 2÷ and M-type K ÷ channels-- pro- 
teins known to influence neuronal excitability (Brown and 
Adams, 1980) and neurotransmitter release (Hirning et al., 
1988). 
Results 
Heterologously Expressed mGluR2 Couples 
to Ca 2+ Channels 
As L-glutamate is primarily a CNS neurotransmitter and 
postganglionic sympathetic neurons do not synapse di- 
rectly with CNS neurons, it was hypothesized that rat supe- 
rior cervical ganglion (SCG) neurons would be devoid of 
GluR responses. This hypothesis was supported by the 
data in Figure 1A, which depicts Ca 2+ current traces re- 
corded from dissociated rat SCG neurons using the whole- 
cell variant of the patch-clamp technique (Hamill et al., 
1981). Ca 2÷ currents were evoked every 10 s with a 70 ms 
depolarizing test pulse to +10 mV from a holding potential 
of -80 mV in solutions designed to isolate voltage- 
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Figure 1. Heterologously Expressed mGluR2 Couples to Ic, in Sympa- 
thetic Neurons 
(A) Absence of Ica modulation by L-glutamate in a control (uninjected) 
neuron. The left panel is a plot of the time course of Ic, amplitude 
(measured isochronally 10 ms from the onset of the test pulse) from an 
uninjected neuron during two applications (closed bars) of L-glutamate 
(100 p,M). Ic, traces from the same neuron in the absence (middle 
panel) or presence (right panel) of L-glutamate were elicited with the 
illustrated voltage protocol (middle panel, lower trace). Neurons were 
voltage-clamped at room temperature (21 °C-24°C) using the whole- 
cell (ruptured patch) variant of the patch-clamp technique in solutions 
designed to isolate Ic~ (see Experimental Procedures). 
(B) Inhibition of Ic~ by L-glutamate in a sympathetic neuron expressing 
mGluR2. Applications of L-glutamate (I 00 I~M; closed bars) produced 
a rapid and reversible depression of Ic~ amplitude (left) in a neuron 
injected previously (16 hr) with in vitro transcribed m RNA (cRNA) cod- 
ing for mGluR2. Note that the Ic~ rising phase trajectory was "slowed" 
in the presence of L-glutamate (right panel). Recording conditions were 
the same as in (A). 
(C) Differential cou piing of mGluR2 and mGluRl~ to Ic,. Mean _+ SEM 
Ica inhibition produced by L-glutamate (100 I~M) in uninjected neurons 
(closed bar) or neurons injected 14-24 hr previously with mGluRlct 
(hatched bar) or mGluR2 (open bar) cRNA. Numbers of neurons tested 
are indicated in parentheses. 
perimental Procedures). In these neurons, the Ca 2+ cur- 
rent has been shown to arise primari ly (65%-95%)  from 
(o-conotoxin GVIA-sensit ive N-type Ca 2+ channels (Plum- 
meret  al., 1989; Ikeda, 1991; Regan et al., 1991; Mintz 
et al., 1992; Boland et al., 1994). Appl icat ion of 100 p,M 
L-glutamate to control (uninjected) neurons produced no 
apparent  alteration in Ca 2+ current ampl i tude or t ime 
course (Figure 1A). In contrast, Ca 2+ current ampl i tude in 
neurons previously (14-24 hr) injected with mGluR2 cRNA 
was greatly attenuated by 100 pM L-glutamate (Figure 
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Figure 2. Ica Modulation Resulting from mGluR2 Activation Is Voltage 
Dependent and Relieved by Depolarizing Prepulses 
(A) Superimposed Ica traces recorded from a mGluR2-injected neuron 
in the absence (lower trace) or presence (upper trace) of L-glutamate 
(100 pM) at test potentials of 0 mV (left panel) or +40 mV (right panel). 
(B) Current-voltage (I-V) relationship for the neuron shown in (A) in 
the absence (open circles) or presence of L-glutamate (closed circles). 
Currents were evoked and amplitudes measured as in Figure 1. 
(C) Plot of Ic~ inhibition versus test pulse potential for the I-V relation- 
ship in (B). 
(D) Superimposed Ica traces recorded with a double-pulse voltage pro- 
tocol (lower inset) in the absence (lower traces) or presence (upper 
traces) of (lS,3R)-ACPD (100 p.M), a mGluR-selective agonist, in a 
mGluR2-injected neuron. The current generated by the first 25 ms 
test pulse to +10 mV is denoted the pre current and the current evoked 
by the second test pulse following a 50 ms conditioning pulse to +80 
mV is denoted the post current. 
(E) Time course of Ica facilitation during ACPD application. Facilitation 
is defined as the ratio of post to pre current (measured at 10 ms after 
the onset of the test pulse). Application of (lS,3R)-AC PD (100 pM) was 
applied during the times indicated (closed bars). Data derived from 
the neuron shown in (D) using an identical voltage protocol. 
1 B, left). This effect was rapid, completely reversible, and 
displayed no apparent  tachyphylaxis  upon a subsequent  
appl ication of agonist. The mean decrease in Ica ampli- 
tude, measured isochronal ly 10 ms from the onset of the 
test pulse, is summar ized in Figure 1C, Ca 2+ current inhibi- 
tion produced by 100 I~M L-glutamate for control (unin- 
jected), mGluRlc~-injected, and mGluR2-injected neurons 
was -0 .57% _ 1.4% (n = 9),6.8°/o --. 4 .0% (n = 9), 
and 63.5% -+ 4.6% (n = 9), respectively. In this set of 
exper iments,  inhibition of Ica was detected in every neuron 
previously injected with mGluR2 cRNA (range, 37%-  
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Figure 3. Agonist Pharmacology of mGluR2-Mediated Ica Inhibition 
(A) Concentration-response for a single neuron. Increasing concentra- 
tions of (lS,3R)-ACPD were applied as indicated (bars) to a neuron 
previously injected with mGluR2 cRNA. Ic, inhibition was determined 
at a test potential of +10 mV as in Figure 1. Note the rapid and complete 
recovery of Ica between applications of different agonist concentra- 
tions. 
(B) Normalized concentration-response curves for mGluR2-mediated 
inhibition of Ica. For the active agonists DCG-IV (open square; n = 5), 
L-glutamate (closed circle; n = 5), and (lS,3R)-ACPD (open circle; n 
= 5), EC50 and maximum inhibition parameters were determined by 
fitting the concentration-response curve for a single neuron, as illus- 
trated in (A), to a single-site binding isotherm with nonlinear regression 
(Marquardt-Levenberg algorithm). Data were then normalized to the 
fitted maximum inhibition and plotted as mean -+- SEM. Solid lines 
represent fits to the mean normalized data, Application of L-AP4, 
L-quisqualate, (1 R,3s)-ACPD (100 ~M; closed square), or L-SOP (10 
~M; open triangle) produced no significant Ic~ inhibition in 3-5 neurons. 
the "willing-reluctant" model (Bean, 1989; Elmslie et al., 
1990; Boland and Bean, 1993) of Ca 2+ channel modulation. 
The effect of voltage on mGluR2-mediated Ic, inhibition 
is illustrated in Figure 2. Figure 2A depicts superimposed 
Ica traces recorded in the absence (lower traces) or pres- 
ence (upper traces) of 100 IX M L-giutamate at two different 
test potentials. Ica inhibition was greater at 0 mV (Figure 
2A, left) than at a test potential of +40 mV (Figure 2A, 
right). Mean Ic~ inhibitions for three neurons determined 
at test potentials of 0 and +40 mV were 51% _+ 5% and 
27% _+ 4%, respectively. Current-voltage relationships 
obtained in the absence or presence of 100 I~M L-glutamate 
are shown as open and closed circles in Figure 2B. The 
highly voltage-dependent nature of mGluR2-mediated Ica 
inhibition is well illustrated by the bell-shaped relationship 
(Figure 2C) between Ica inhibition and test pulse potential 
(Ikeda, 1992; Zhu and Ikeda, 1993). Maximal inhibition 
occurred over the voltage range of 0 to 10 mV. The ability 
of large depolarizing conditioning pulses to relieve 
mGluR2-mediated Ica inhibition is illustrated in Figure 2D. 
Ca 2÷ currents were evoked with a double-pulse voltage 
protocol (Elmslie et al., 1990) in the absence (Figure 2D, 
lower trace) or presence (Figure 2D, upper trace) of 100 
~.M (1S,3R)-l-aminocyclopentane-l,3-dicarboxylic acid 
(ACPD), a mGluR-selective agonist. Under control condi- 
tions, the current evoked following a large depolarization 
(post current) was slightly larger ( -  16%; see Ikeda, 1991) 
than the current generated by an identical test pulse pre- 
ceding the conditioning pulse (pre current). Application of 
100 ~M (1S,3R)-ACPD produced a 62% decrease in pre 
current amplitude and characteristic slowing of the current 
rising phase. In contrast, the post current was depressed 
only 18% and no longer exhibited an altered time course. 
For five neurons, application of 100 I~M L-glutamate or 
(lS,3R)-ACPD produced a 68% _ 3% decrease in the 
pre current and only a 27% __. 3% decrease in the post 
current. Thus, the 50 ms conditioning pulse to +80 mV 
relieved the majority, but not all, of the Ica inhibition pro- 
duced by (1S,3R)-ACPD. Finally, the ratio of post to pre 
current, or facilitation, is increased rapidly and reversibly 
by mGluR2 activation (Figure 2E). Mean facilitation in- 
creased from 1.10 _ 0.02 to 2.55 _ 0.14 (n = 5)during 
application of 100 t~M L-glutamate or (1S,3R)-ACPD. 
770). Conversely, Ica of neurons previously injected with 
mGluRle cRNA was unaffected (<10% inhibition) in six 
of nine neurons; three neurons demonstrated small inhibi- 
tions (range, 13o-26o) .  
The rising phase of Ica in the presence of L-glutamate 
exhibited a prom inent biphasic or "slowed" trajectory (Fig- 
ure 1 B, right) reminiscent of the effect produced by activa- 
tion of several natively expressed G protein-coupled re- 
ceptors, for example, somatostatin (Ikeda and Schofield, 
1989), e2-adrenergic (Schofield, 1991), prostaglandin 
(Ikeda, i992), adenosine (Zhu and Ikeda, 1993), and VIP/ 
secretin (Zhu and Ikeda, 1994). The "slowing" of the activa- 
tion phase has been proposed to arise from a voltage- 
dependent relief of block during the test pulse and can 
be accounted for, at least qualitatively, by variations of 
Pharmacology of mGluR2-Mediated Ic. Inhibition 
The agonist pharmacology of mGluR2-mediated lea inhibi- 
tion was characterized as illustrated in Figure 3. Figure 
3A depicts the protocol used to derive concentration- 
response curves for a series of mGluR agonists. Ca 2÷ cur- 
rents were evoked every 10 s with 70 ms test pulse to +10 
mV from a holding potential of -80 mV. Note that maximal 
inhibition occurred near this test pulse potential (see Fig- 
ure 2C). After the current amplitude had stabilized follow- 
ing patch rupture, increasing concentrations of a single 
agonist were sequentially applied to a single neuron for 
periods of about 20 s (Figure 3A, bars), a time sufficient 
for Ica inhibition to reach maximum values. Between drug 
applications, Ica rapidly (10-20 s) recovered to near base- 
line amplitude. The normalized concentration-response 
Neuron 
1032 
curve for an agonist (Figure 3B) was determined by fitting 
(nonlinear least squares) a single binding site isotherm 
(Figure 3B, solid line) to the Ica inhibition data and then 
normalizing the data to the maximum inhibition parameter. 
The rank order of agonist potency for mGlu R2-mediated Ica 
inhibition obtained in this way was DCG-IV > L-glutamate > 
(IS,3R)-ACPD >> L-SOP, L-AP4, L-quisqualate, (1R,3$)- 
ACPD. For the three active agonists, the mean EC~0 for 
DCG-IV (n = 5), L-glutamate (n = 5), and (lS,3R)-ACPD 
(n = 5) inhibition of Ica was 0.11 _+ 0.02 I~M, 1.8 _+ 0.4 
I~M, and 3.7 _+ 0.2 ~M, respectively, and the maximum 
block of lca was 45% _+ 5% , 48% _+ 12%,and56% _+ 
4%, respectively. 
The impotency of both L-quisqualate and L-AP4 in re- 
gard to Ic, inhibition is particularly important in that these 
compounds have been shown to inhibit high threshold 
Ca 2÷ channels in CNS neurons. In fact, L-quisqualate was 
the most potent agonist in depressing Ica of acutely iso- 
lated hippocampal CA3 pyramidal neurons (Swartz and 
Bean, 1992). Th us, these com pounds were always "brack- 
eted" with active agonists serving as positive controls to 
assure that lack of agonist response could not be attrib- 
uted to variations in mGluR2 expression or desensitiza- 
tion. Successive application of 100 I~M L-glutamate, 
L-AP4, L-quisqualate, and (lS,3R)-ACPD to single neurons 
(n = 4) resulted in mean Ica inhibition of 52% __ 9%, 4.70/0 
__ 1.7%, 3.1% __. 1.6%, and 44% _+ 6.9%, respectively 
(data not shown). The stereoselectivity of agonist re- 
sponse was determined using resolved enantiomers of 
trans-ACPD. Application of 100 I~M (18,3R)-ACPD, (1R,3S)- 
ACPD, and (lS,3R)-ACPD in succession to single neurons 
(n = 4) resulted in mean Ica inhibition of 58% _+ 6%, 2.6 
-4- 1.5%, and 57% __ 6%, respectively (data not shown). 
Figure 4A illustrates the effect of the mGluR antagonist 
( _+ )-~-methyl-4-carboxyphenylglycine (MCPG; Hayashi et 
al., 1994). A "bracketed" protocol was used to evaluate 
the ability of 500 I~M MCPG to antagonize Ic~ inhibition 
produced by 3 I~M (lS,3R)-ACPD (a concentration approxi- 
mately equal to the ECso). Successive applications of 3 
I~M (tS,3R)-ACPD (first application), 500 I~M (--4-)-MCPG, 
( _ )-MCPG/(1S,3R)-ACPD combined, and (lS,3R)-ACPD 
(second application) to single neurons (n = 4) resulted in 
mean Ica inhibition of 39% -+ 5%, 3.6% - 1.0% , 10% 
_ 20,  and 36% + 2%, respectively (Figure 4B). Thus, 
(_+)-MCPG alone produced no detectable Ica inhibition but 
effectively and reversibly antagonized (lS,3R)-ACPD- 
induced Ica inhibition. 
Heterologously Expressed mGluRl~ Couples to 
M-type K* Channels 
The M current (IM) is a noninactivating K÷ conductance 
found in both PNS and CNS neurons that is highly modu- 
lated and known to influence electrical excitability (Brown 
and Adams, 1980). IM recordings from SCG neurons were 
made with the whole-cell patch-clamp technique using pi- 
pette and external solutions that approximate physiologi- 
cal conditions (see Experimental Procedures). SCG neu- 
rons were voltage-clamped at a holding potential of -30 
mV (which serves to inactivate other K ÷ currents)'and peri- 
odically (0.1 Hz) stepped to -60 mV for 0.5 s (Figure 5A, left 
trace). IM amplitude was determined from the magnitude of 
the slow"tail current" (Figure 5A, left trace, arrows), which 
results from M channel deactivation during the sojourn to 
-60 mV. Under these conditions, application of L-glutamate 
(100 p.M) to control neurons (i.e., uninjected) produced no 
apparent change in the IM amplitude or time course (Figure 
5A, left and right trace). In addition, there was no detectable 
change in steady-state current at either -30 mV or -60 
mV; hence iGluR-mediated responses are not present in 
SCG neurons, at least under these conditions. In neurons 
that had been injected 14-24 hr prior to recording with 
mGluRla cRNA, application of L-glutamate (100 I~M) re- 
sulted in a rapid and reversible inhibition of IM amplitude 
(Figure 5B, left). The inhibition was characterized by a 
decrease in both the steady-state outward current at -30 
mV and the time-dependent current relaxation at -60 mV 
(Figure 5B, right trace). Similar effects are produced by 
activation of natively expressed muscarinic acetylcholine 
receptors in these neurons (Brown et al., 1989; Beech et 
al., 1991; Bernheim et al., 1992). Figure 5C summarizes 
the decrease in IM amplitude produced by L-glutamate (100 
I~M). Mean inhibition of IM amplitude for control (unin- 
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Figure 4. ACPD-Mediated Ica Inhibition Is Antagonized by MCPG in 
mGluR2-1njected Neurons 
(A) Time course of Ica inhibition following successive applications (indi- 
cated by bars) of 3 ~M (lS,3R)-ACPD, 500 p_M ( ± )-MCPG, a combina- 
tion of 3 I~M (ls,3R)-ACPD and 500 p.M (±)-MCPG, and a repeat 
application of ACPD. Ica traces (inset) correspond to time points indi- 
cated. Currents were recorded and analyzed as in Figure 1. Note that 
the concentration of(lS,3R)-ACPD was near the ECso (Figure 3B) for 
lea inhibition. 
(B) Mean ± SEM Ic, inhibition for successive applications of agonist 
and antagonist as described above. Number of neurons tested are 
indicated in parentheses. 
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Figure 5. Heterologously Expressed mGluRla Couples to IM in Sym- 
pathetic Neurons 
(A) Absence of IM modulation by L-glutamate in control (uninjected) 
SCG neurons. Time course of IM amplitude (left panel) during applica- 
tion of 100 pM L-glutamate (bar). IM amplitude was measured as the 
difference in current between the beginning and end of a 500 ms 
hyperpolarizing voltage step to -60 mV (arrows in middle panel) elic- 
ited at 10 s intervals from a holding potential of-30 mV. Representative 
current traces of IM in the absence (middle panel) or presence (right 
panel) of 100 pM L-glutamate are shown. IM contributed to both the 
steady-state current at -30 mV and time-dependent relaxation (deacti- 
vation) upon stepping to -60 inV. Note that the absence of change 
in steady-state current (at both -30 and -60 mV) during L-glutamate 
application suggests that ionotropic receptors are not present on SCG 
neurons. Neurons were voltage-clamped at room temperature (21 °C- 
24°C) using the whole-cell (ruptured patch) variant of the patch-clamp 
technique. Dashed lines represent the zero current level. 
(B) Inhibition of IM by L-glutamate in a sympathetic neuron expressing 
mGluRle. Application of 100 pM L-glutamate (bar) resulted in a rapid 
and reversible inhibition of IM amplitude (left panel). Complete recovery 
of I~ amplitude was not always seen, especially with prolonged applica- 
tion of agonist (>60 s). Current traces evoked as in (A) in the absence 
(middle panel) or presence (right panel) of 100 p.M L-glutamate. Note 
the decrease in steady-state current and near abolition of the time- 
dependent relaxation at -60 mV. Dashed lines represent the zero 
current level. 
(C) Differential coupling of mGluR1 ~ and mGluR2 to IM. Mean _+ SEM 
inhibition of IM amplitude for uninjected neurons (closed bar) or neurons 
previously (14-24 hr) injected with mGluR1 cz (hatched bar) or mGluR2 
(open bar) cRNA. Current inhibition was determined from traces ac- 
quired just prior to and during application of 100 lzM L-glutamate for 
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Figure 6. Agonist Pharmacology of mGluRla-Mediated IM Inhibition 
(A) Cumulative concentration-response for a single neuron previously 
injected with mGluR1 c~ cRNA. Increasing concentrations of glutamate 
were applied as indicated (bars). IM amplitude was determined at -60 
mV as in Figure 5. There was often little recovery of IM following pro- 
longed administration of agonists. 
(B) Normalized concentration-response curves for mGluRl{x- 
mediated inhibition of IM. For the agonists L-quisquaiate (open trian- 
gles; n = 5), L-glutamate (closed circles; n = 5), and (1S,3R)-ACPD 
(open circles; n = 5), EC~ and maximum inhibition parameters were 
determined by fitting the concentration-response curve for a single 
neuron, as illustrated in (A), to a single-site binding isotherm with non- 
linear regression (Marquardt-Levenberg algorithm). Data were then 
normalized to the fitted maximum inhibition and plotted as mean 
SEM Solid lines represent fits to the mean normalized data. Applica- 
tion of 10 p.M DCG-IV (open square; n = 4) or 100 p.M L-AP4 (open 
diamond; n = 2) produced negligible inhibition of IM. 
was 1.4% _+ 1% (n = 12), 81% _+ 5% (n = 10), and 
-0.4% _+ 2.4% (n = 8), respectively. 
Pharmacology of mGluRla-Mediated |M Inhibition 
The agonist pharmaco logy of mGluR la -med ia ted  IM in- 
hibition was character ized as il lustrated in Figure 6. To 
generate concentrat ion- response curves, increasing con- 
centrations of agonist were sequential ly applied to a 
mGluRl~- in jected neuron, and the magnitude of I~ inhibi- 
tion was determined when the response had reached a 
steady value. Because recovery from IM inhibition was rela- 
tively slow (see Figure 5B) and often incomplete (espe- 
cially after pro longed administrat ion of agonist), agonist 
concentrat ions were appl ied before recovery from the pre- 
vious concentrat ion had occurred (i.e., the data represent 
a cumulat ive concentrat ion- response curve). Normal ized 
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Figure 7. Distinct Signal Transduction Pathways Mediate mGluR2- 
Mediated Inhibition of Ica and mGluRl~z-Mediated Inhibition of IM 
(A) mGluR2-mediated Ic, inhibition istransduced via a PTX-sensitive 
G protein. The upper set of bars represent the mean _+ SEM inhibition 
of Ic, (produced by 100 I~M L-glutamate) determined 5 min after dialyz- 
ing mGluR2-injected neurons with either control Ica pipette solution 
(open bar) or pipette solution in which GTP was replaced with 2 mM 
GDP-~-S, a hydrolysis-resistant GDP analog (hatched bar). The lower 
set of bars represent mean _+ SEM inhibition of Ica produced by 100 
p.M L-glutamate incontrol (open bar) or PTX-treated mGluR2-injected 
neurons (closed bar). 
(B) mGluRl(~-mediated IM inhibition istransduced via a PTX-insensitive 
G protein, The upper set of bars represents he mean _+ SEM inhibition 
of In determined 5 min after dialyzing mGluRls-injected neurons with 
either control IM pipette solution (containing 6 mM LiCI; open bar) or 
pipette solution in which GTP was replaced with 2 mM Li3-GDP-~-S 
(hatched bar). The lower set of bars represent mean _+ SEM inhibition 
of IM produced by 100 pM I.-glutamate incontrol (open bar) or PTX- 
treated mGluRls-injected neurons (closed bar). 
In both (A) and (B), PTX-treated neurons were incubated overnight 
(12-15 hr) with culture media containing 500 ng/ml PTX. In inhibition 
was determined as in Figure 5. The number of neurons tested are 
indicated in parentheses. Single asterisk, p ~< .05; double asterisks, 
p ~ .01 (unpaired Student's t test). 
as in Figure 3. For mGluRl(z-mediated IM inhibition, the 
rank order of agonist potency was L-quisqualate > 
L-glutamate > (1S,3R)-ACPD >> L-AP4, DCG-IV. The 
mean ECs0 for L-quisqualate (n = 5), L-glutamate (n = 
5), and (lS,3R)-ACPD (n -- 5) inhibition of IM was 0.044 
± 0.005 I~M, 0.66 ± 0.06 I~M, and 10 _+ 4 I~M, respec- 
tively, and the maximum inhibition was 75% ± 4%, 77% 
_+ 3%, and 64% + 7%, respectively. Application of 10 
I~M DCG-IV and 100 [~M L-AP4 resulted in 6.4% _ 2.4% 
(n = 4) and 3.0% ± 0.8% (n -- 2) inhibition of IM, respec- 
tively. 
The ability of (+)-MCPG (the active enantiomer) to block 
the inhibition of IM produced by application of L-glutamate 
was examined (data not shown). Application of agonist in 
the absence or presence of (+)-MCPG was performed on 
different neurons, as recovery from IM inhibition was often 
incomplete. In the absence or presence of 500 I~M 
(+)-MCPG, application of 10 I~M L-glutamate resulted in 
79% + 8% (n -- 4) and 58% __. 7% (n = 5) inhibition of 
IM, respectively. However, the difference in mean inhibition 
was not significant (p = .1). 
Signal Transduct ion Pathways  
The role of G proteins in the signal transduction pathway 
through which activation of mGluR2 inhibits lea was investi- 
gated (Figure 7A). Guanosine 5'-O-2-thiodiphosphate 
(GDP-I~-S), a hydrolysis-resistant GDP analog, has been 
shown to attenuate G protein-mediated responses (Holz 
et al., 1986; Wanke et al., 1987), perhaps by acting as a 
competitive inhibitor of GTP binding to G(z subunits 
(Eckstein et al., 1979). Inhibition of Ica by L-glutamate (100 
I~M) was determined 5 min after dialysis of a mGluR2- 
injected neuron with a pipette solution containing either 
0.3 mM GTP (Figure 7A, top open bar) or 2 mM GDP-13-S 
(without GTP; Figure 7A, hatched bar). Mean Ico inhibition 
in the absence or presence of internal GDP-I~-S was 53% 
__. 6.3% (n = 8) and 7.1% _.+ 3.4% (n = 6), respectively, 
thus implicating the participation of a G protein in the trans- 
duction pathway. Experiments to identify further the G 
protein subtype were carried out on pertussis toxin (PTX)- 
treated neurons. PTX is known to catalyze the ADP- 
ribosylation of a carboxy-terminal cysteine on the (z subunit 
of PTX-sensitive G proteins (G~ and Go), thereby disrupting 
pathways that utilize these elements (Hepler and Gilman, 
1992). PTX treatment abolished the mGluR2-mediated Ico 
inhibition; mean Ic~ inhibition produced by L-glutamate 
(100 I~M) was 69°/0 __. 30/o (n = 5) and -2.7°/o ± 0 .9% 
(n = 6) for control (Figure 7A, lower open bar) and PTX- 
treated neurons (Figure 7A, closed bar), respectively. 
Analogous experiments were performed to investigate 
signal transduction pathways involved in mGluRl(z-medi- 
ated IM inhibition (Figure 7B). Dialysis of mG luR1 (z-injected 
neurons with GDP-I~-S significantly (p < .05) reduced IM 
inhibition by L-glutamate (100 ~M) in mGluRl(z-injected 
neurons. Mean IM inhibition in the absence (Figure 7B, 
upper open bar) or presence (Figure 7B, hatched bar) of 
internal GDP-I~-S was 79% _ 11% (n = 4) and 26% __. 
11% (n = 4), respectively. Conversely, PTX treatment 
had no effect on mGluRl(z-mediated IM in.hibition. Mean 
IM inhibition produced by L-glutamate (100 tIM) was 790/0 
_ 6% (n = 6) and 76% ± 5% (n = 7), for control (Figure 
7B, lower open bar) and PTX-treated neurons (Figure 7B, 
closed bar), respectively. 
Discussion 
In this study, we have demonstrated that injection of cRNA 
into the cytoplasm of adult mammalian sympathetic neu- 
rons results in rapid and robust expression of mGluRs 
that functionally couple to endogenous voltage-gated ion 
channels. As currently available pharmacological gents 
have a limited ability to discriminate among the growing 
number of mGluR subtypes, our current knowledge of the 
physiological roles subserved by specific mGluR subtypes 
relies heavily on extrapolation from nonneuronal prepara- 
tions. The experimental strategy presented here thus fills 
an important void in our understanding of mGluR function 
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by providing a means of investigating the interaction be- 
tween unambiguously identified mGluR subtypes and 
neuronal ion channels. 
Sympathetic Neurons as Expression Hosts 
Mature sympathetic neurons, as a heterologous expres- 
sion host, are endowed with several properties useful for 
studying G protein-coupled receptor function. First, sym- 
pathetic neurons possess a fairly homogenous comple- 
ment of well studied voltage-gated ion channels to which 
expressed receptors might potentially couple. For exam- 
ple, modulation of N-type Ca 2+ channels and M-type K + 
channels--proteins that participate in the regulation of 
neurotransmitter release and neuronal excitability--has 
been studied extensively in this cell type (reviewed by 
Hille, 1994). Second, we detected expression within 14- 
24 hr following injection. As a consequence, recordings 
were made before significant neurite formation, and thus 
degradation of voltage-clamp fidelity due to inadequate 
space-clamping occurred. In addition, the rapid expres- 
sion observed in these studies compares favorably with 
the weeks, or even months, required for stable transfection 
studies. Third, expression was detected in nearly every 
injected cell, an advantage when compared with the vari- 
able expression rates achievable with other systems of 
transient ransfection (e.g., calcium phosphate precipita- 
tion or lipofection). Fourth, in this study, mGluR subtypes 
were expressed against a "null" background. Thus, the 
mGluR subtype mediating a response was unambiguously 
defined, and interference from other mGluR and iGluR 
subtypes was eliminated. This obviated the need for com- 
plex pharmacological mixtures of antagonists--often a re- 
quirement when attempting to assess the contribution of 
a specific mGluR subtype in CNS neurons--that could 
potentially confound data interpretation. Finally, we antici- 
pate that sympathetic neurons, as expression hosts, will 
be generally useful for the study of G protein-coupled 
receptor structure/function. There are few, if any, expres- 
sion systems in which mutant~chimeric eceptors can be 
rapidly expressed and tested for functional coupling to 
neuronal ion channels. To date, studies of chimeric mGluR 
receptor function have been determined from biochemical 
assays (e.g., changes in cAMP or IP3) in transfected non- 
neuronal cells (O'Hara et al., 1993; Takahashi et al., 1993; 
Pin et al., 1994). Thus, our knowledge of the requirements 
for mGluR coupling to the G protein subtype Go, presum- 
ably important o N-type Ca 2+ channel modulation in SCG 
neurons (Caulfield et al., 1994), is minimal. 
Coupling of mGluRs to Ion Channels 
Using this neuronal expression system, we have demon- 
strated that mGluR2 couples to N-type Ca 2+ channels via 
a PTX-sensitive pathway, mGluR2-mediated Ic~ inhibition 
was characterized by a slowing of current activation, pro- 
nounced voltage dependence of inhibition, and partial re- 
lief of block by depolarizing conditioning pulses. Such 
characteristics are produced by activation of several na- 
tive G protein-coupled receptors and define the major 
pathway for Ica modulation in sympathetic neurons (re- 
viewed by Hille, 1994). That mGluR2 follows this profile 
of Ica inhibition is consistent with the fact that most, if not 
all, endogenous receptors in SCG neurons that utilize the 
PTX-sensitive voltage-dependent pathway are also known 
to negatively couple to AC. In addition, the expression of 
mGluRl~, a subtype that does not inhibit AC when ex- 
pressed in nonneuronal cells, produced minimal Ca 2+ 
channel modulation. However, the relationship between 
AC inhibition and Ioa inhibition is probably not causal, as 
it is well established that N-type Ca 2+ channels of rat sym- 
pathetic neurons are relatively insensitive to modulation 
by cAMP (Wanke et al., 1987; Ikeda and Schofield, 1989). 
Thus, it is likely that the signal transduction pathways me- 
diating these responses diverge subsequent to agonist- 
receptor binding, a notion supported by the observations 
that G~ mediates AC inhibition (Hepler and Gilman, 1992), 
and Go may mediate Ica modulation (Caulfield et al., 1994). 
It remains to be determined whether other mGluR sub- 
types (mGluR3, mGluR4, mGluR6, and mGluR7) that neg- 
atively couple to AC also inhibit N-type Ca 2+ channels. 
Our studies also demonstrate that mGluRla, but not 
mGluR2, couples to M-type K + channels via a PTX- 
insensitive pathway when expressed in SCG neurons. 
This result is consistent with the fact that both muscarine 
(Brown et al., 1989) and angiotensin II (Shapiro et al., 
1994), agents that produce IM inhibition in SCG neurons 
via a PTX-insensitive pathway, act through receptors 
known to increase IP3 formation. However, neither IP~ nor 
diacylglycerol appear to be directly involVed in the mecha- 
nism of IM inhibition (Brown et al., 1989). Thus, it is possible 
that activation of Gq~, represents the event common to 
both IM inhibition (Caulfield et al., 1994) and phospholipase 
C activation. Interestingly, both muscarine (Beech et al., 
1991; Bernheim et al., 1991) and angiotensin II (Shapiro 
et al., 1994) have been shown to suppress Ica in SCG 
neurons through a novel pathway that is PTX insensitive, 
voltage independent, nonmembrane delimited, and sensi- 
tive to intracellular Ca 2+ buffers; thus, it will be important 
to determine in future experiments whether mGluRlcz pro- 
duces Ica inhibition under similar conditions. 
Comparison of Heterologous Expression in SCG .... 
Neurons and Nonneuronal Cells 
The identification of mGluR subtypes mediating ion chan-: 
nel modulation in CNS neurons relies heavily on compar- 
ing the agonist pharmacology of CNS neurons with non- 
neuronal cells expressing mGluRs. The difficulties in 
performing binding studies on mGluRs (e.g., low affinity 
of ligands and nonspecific binding contributed by reuptake 
mechanisms) have resulted in the agonist pharmacology 
of the cloned mGluRs being derived almost exclusively 
from biochemical assays. Thus, it is important o compare 
the results of this study with those obtained from nonneu- 
ronal;:expression systems. For mGluR2-mediated Ic~ inhi- 
bition in SCG neurons, the rank order of agonist potency 
(DCG-IV > L-glutamate > (lS,3R)-ACPD) was identical to 
data obtained from measuring agonist-induced suppres- 
sion of forskolin-stimulated cAMP production in CHO cells 
stably transfected with mGluR2 (Tanabe et al., 1992; Hay- 
ashi et al., 1993). In both systems, these agonists had 
similar efficacy (i.e., none were partial agonists) and ECho 
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values (cf. 0.1 and 0.3 pM, DCG-IV; 1.8 and 4 p.M, L-glu- 
tamate; and 3.7 and 5 I~M, (lS,3R)-ACPD; for SCG and 
CHO cells, respectively). Moreover, MCPG was an effec- 
tive.antagonist of, and PTX-pretreatment abolished, the 
mGluR2-mediated responses in both SCG neurons and 
CHO cells (Tanabe et al., 1992; Hayashi et al. 1994). Thus, 
there is reasonably good agreement between the two sys- 
tems despite the disparity in expression host and response 
measured, 
Conversely, comparison of mGluR1 (~-mediated IM inhibi- 
tion in SCG neurons with IP formation in nonneuronal 
(CHO, BHK, and HEK293) cells reveals several discrepan- 
cies. First, although the rank order of agonist potency for 
L-quisqualate, L-glutamate, and (1S,3R)-ACPD was the 
same for neuronal and nonneuronal cells, the agonist po- 
tency was considerably greater for IM inhibition. For exam- 
ple, the ECso for mGluRl(z-mediated IP turnover in BHK 
cells (Thornsen et al., 1993) was 3, 12, and 98 I~M for 
L-quisqualate, L-glutamate, and (lS,3R)-ACPD, respec- 
t ively-values at least an order of magnitude greater than 
the those for IM inhibition (see Figure 6B). Second, L-quis- 
qualate and ACPD are partial agonists (when compared 
with L-glutamate) in CHO cells (Aramori and Nakanishi, 
1992) but full agonists (or at least had comparable efficacy) 
in SCG neurons. Third, MCPG is an effective antagonist 
of L-glutamate in mGluRl(z-expressing CHO cells (Hay- 
ashi et al., 1993) but had minimal effect in SCG neurons. 
The reason for this difference is unclear but may relate 
to the high potency of glutamate agonists in mGluRl(~- 
expressing SCG neurons (see above) and the fact that 
MCPG, although selective for mGluRs relative toiGluRs, 
is a relatively weak competitive antagonist (Hayashi et al., 
1994). Fourth, mGluRl(x-mediated IP turnover in both 
CHO (Aramori and Nakanishi, 1992)and BHK (Thomsen 
et al., 1993) cells is partially (40O/o-500/0) inhibited by PTX 
pretreatment. In contrast, mGluRle.mediated inhibition 
of IM in SCG neurons was not significantly affected by PTX 
pretreatment (see Figure 7B). Thus, data obtained from 
mGluRl(z-transfected nonneuronal cells are only moder- 
ately predictive of the characteristics of mGluRl(~-mediated 
ion channel modulation in neurons. Moreover, the discrep- 
ancy in results obtained among different nonneuronal ex- 
pression hosts stably transfected with mGluRl(~ (e.g., Ga- 
bellini et al., 1994) underscores the need to develop 
alternative neuronal expression systems. 
Functional Correlates in CNS Neurons 
The mGluR2-mediated inhibition of Ica observed in SCG 
neurons appears to have correlates in the CNS. For exam- 
ple, DCG-IV or L-CCG-I, agonists selective for mGluR2/3 
(Hayashi et al., 1992, 1993), produce synaptic depression 
at corticostriatal synapses (Lovinger and McCool, 1995) 
and inhibition of high threshold Ic, in cerebellar granule 
cells (Chavis et al., 1994) and Cortical neurons (unpub- 
lished data). Moreover, DCG-IV inhibits 7-aminobutyric 
acid release from gran~Jle cells of the accessory olfactory 
bulb, presumably through the activation of mGluR2 (Hay- 
ashi et al., 1.993). On the other hand,inhibition of neuronal 
Ca channe s by L-quwsqua ate (Lester and high threshold 2+ • ~ ' 
Jahr, 1990; Swartz and Bean, 1992; Hay and Kunze, 1994) 
and L-AP4 (Trombley and Westbrook, 1992; Sahara and 
Westbrook, 1993), a result not seen in this study, has been 
reported. Thus, we assume that additional mGluR sub- 
types distinct from mGluR2 must also mediate Ica modula- 
tion in CNS neurons. 
In this regard, the results of Swartz and Bean (1992) 
are of particular interest. In this study, L-glutamate pro- 
duced an inhibition of N-type Ca 2+ channels in dissociated 
rat hippocampal CA3 neurons accompanied by much of 
the same voltage-dependent phenomenology observed 
for mGluR2-mediated ica inhibition in SCG neurons (see 
Figure 2). In contrast to the present result, however, 
L-quisqualate was the most potent agonist in hippocampal 
neurons. The finding that Ica in mGluRl(~-expressing SCG 
neurons (see Figure 1C) was only slightly modulated by 
L-glutamate (see Figure 1C) suggests that another group 
I mGluR (i.e., splice variants of mGluR1 or mGluR5), or 
possibly a novel mGluR, is responsible for Ic, inhibition in 
CA3 hippocampal neurons. Alternatively, itis possible that 
mGluRl(z, the sole mGluR subtype shown to stimulate 
AC in nonneuronal cells (Aramori and Nakanishi, 1992; 
O'Hara et aL, 1993), mediates inhibition of N-type Ca 2÷ 
channels via a recently described pathway (Zhu and Ikeda, 
1994) involving the activation of Gs. In this case, the weak 
mGluRl~-mediated inhibition of Ica in SCG neurons might 
be related to the level of receptor expression (see O'Hara 
et al., 1993). 
The observations that mGluR agonists produce IM inhibi- 
tion in neurons of the hippocampus (Charpak et al., 1990), 
nucleus of the solitary tract (Glaum and Miller, 1992), and 
basolateral amygdala (Womble and Moises, 1994) provide 
a functional correlate to our findings with heterologously 
expressed mGluRlm The mGluR subtype mediating IM 
inhibition in CNS neurons is currently unresolved. How- 
ever, the report that L-quisqualate inhibits IM in hippocam- 
pal neurons (Charpak et al., 1990) is consistent with our 
observations. The inability of mGluR2 to modulate IM (see 
Figure 5C) reinforces the notion that mGluRs couple to 
specific ion channels. 
Experimental Procedures 
Neuron Preparation and ¢RNA Injection 
Single SCG neurons were enzymatically dissociated from 150.-400 g
male or female Wistar rats as previously described (Ikeda, 1991; Zhu 
and Ikeda, 1994). After allowing 2-4 hr for the neurons to attach firmly 
to the substrate (poly-D-lysine), neurons were microinjected using an 
Eppendorf 5242 pressure (N2) microinjector and 5171 micromanipula- 
tor system with cR NA (pipette concentration, 0.5-2.5 p.g/Id). The cRNA 
was mixed with a coinjection marker (10,000 MW fluorescein dextran, 
0.1% in water) as previously described (Ikeda et al., 1992). Injection 
pressures and durations of 120-200 hPa and 0.4-0.5 s, respectively, 
resulted in an estimated 10% increase in cell volume, cRNA was in 
vitro transcribed in the presence of cap analog mT(5')ppp(5')G from 
linearized plasmids (pBluescript II KS+) using mMessage mMachine 
kits (Ambion) per the instructions ofthe manufacturer. After incubation 
(37°C, 5% CO2 in air) in culture media (minimal essential media supple- 
mented with 10% fetal calf serum and 1% penicillin-streptomycin 
[GIBCO]) for 14.-24 hr, injected neurons were identified with an in- 
'k, erted microscope (Diaphot, Nikon, Japan) equipped with an epifluo- 
rescence unit. PTX (final concentration, 500 ng/ml; List Biologicals) 
was added to culture rfiedia 1-2 hr following neuron.injection. 
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Electrophysiology 
Whole-cell currents were recorded with a patch-clamp amplifier (Axo- 
patch 200A or 1 D, Axon Instruments) at room temperature (21-24°C) 
using the ruptured-membrane variant of the patch-clamp technique 
(Hamill et al., 1981) as previously described (Zhu and Ikeda, 1994). 
For recording of Ic~, the external solution consisted of 140 mM tetraeth- 
ylammonium hydroxide, 10 mM HEPES, 10 m M CaCI2, 15 mM glucose, 
and 0.0001 mM tetrodotoxin (pH adjusted to 7.4 with methanesulfonic 
acid). Patch electrodes (2-6 M~) were filled with a solution consisting 
of 125 mM N-methyI-D-glucamine, 20 mM tetraethylammonium-OH, 
t0 mM HEPES, 11 mM EGTA, 1 mM CaCI2, 14 mM Tris-creatine 
phosphate, 4 mM MgATP, 0.3 mM Na2-GTP (pH adjusted to 7.2 with 
methanesulfonic acid and HCI [final CI- concentration of 20 raM]). Ica 
traces were filtered at 2-5 KHz and digitized at 5 KHz. For In re- 
cordings, external solution consisted of 150 mM NaCI, 2.5 mM KCI, 
10 mM HEPES, 1 mM MgCI2, 1 mM CaCI2, 15 mM glucose, 0.0001 
mM tetrodotoxin (pH adjusted to 7.4 with NaOH). Patch electrodes 
(1-4 M~) were filled with a solution consisting of 150 mM KCI, K4- 
BAPTA (1,2-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetracetic acid, 
0.1), 10 mM HEPES, 4 mM Mg-ATP, 0.1 mM Na2-GTP (pH adjusted 
to 7.2 with KOH). IM traces were filtered at 0.5-1 KHz and digitized at 
500 Hz. Drugs were applied from a large-bore macropipette positioned 
near (20-30 pro) the neuron of interest. L-quisqualate, (lS,3R)-ACPD, 
(1R,3S)-ACPD, (___) MCPG, (+) MCPG, L-SOP, and L-AP4 were pur- 
chased from Tocris Neuramin (United Kingdom). L-glutamate was pur- 
chased from Fisher Scientific (USA). Na2-GTP, Tris-creatine phos- 
phate, and Li3-GDP-13-S were purchased from Sigma (USA). DCG-IV 
was kindly provided by Drs. H. Shinozaki and Y. Ohfune. 
Analysis 
Ca 2+ current traces and current-voltage relationships were corrected 
for linear leakage current as determined from hyperpolarizing pulses. 
Ica amplitude was determined isochronally 10 ms after the onset of a 
test pulse unless otherwise noted. M current traces were not leak 
subtracted. Nonlinear least squares regression of binding isotherm 
data was performed with curve-fitting routines (Marquardt-Levenberg 
algorithm) in Igor (WaveMetrics, USA). Data were expressed as means 
4-_ SEM as appropriate. Student's t test (unpaired) was applied to 
determine statistical significance. The differences were considered 
significant if p ~< .05. 
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